The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evolution of heterogeneous mechanisms of acquired resistance to cetuximab-based therapy in colorectal cancer.
Clara Montagut
No relevant relationships to disclose
Beatriz Bellosillo
No relevant relationships to disclose
Iria Gonzalez
No relevant relationships to disclose
Alejandro Martinez
No relevant relationships to disclose
Alba Dalmases
No relevant relationships to disclose
Mar Iglesias
No relevant relationships to disclose
Joana Vidal
No relevant relationships to disclose
Marta Salido
No relevant relationships to disclose
Mar Garcia
No relevant relationships to disclose
Marcos Busto
No relevant relationships to disclose
Guadalupe Aguilar
No relevant relationships to disclose
Ester Moragon
No relevant relationships to disclose
Blanca Espinet
No relevant relationships to disclose
Sergi Serrano
No relevant relationships to disclose
Ana Rovira
No relevant relationships to disclose
Joaquim Bellmunt
No relevant relationships to disclose
Joan Albanell
No relevant relationships to disclose